Skip to main content
. Author manuscript; available in PMC: 2012 Dec 4.
Published in final edited form as: Mol Psychiatry. 2008 May 6;14(12):1095–1104. doi: 10.1038/mp.2008.48

Figure 1.

Figure 1

Depressive and fatigue symptom scores in the two interleukin-6 (IL-6) genotype groups. Symptoms are expressed as effect size (mean change from baseline ± s.e.m.) during 24 weeks of interferon-α (IFN-α) and ribavirin treatment. (a) Subjects with the CC genotype (n = 15) experienced significantly fewer depressive symptoms than the combined GG and GC genotype group (n = 83) (P = 0.002). (b) There was no difference in fatigue symptoms experienced by the CC genotype (n = 15) and the combined GG and GC genotype group (n = 83) (P = 0.3).